Be the first person to write a business review for HP Laboratories

hte offers materials research and discovery services for companies in the chemical and pharmaceuticals industries using high-throughput experimentation equipment. hte Aktiengesellschaft focuses on catalysis research for use in oil and gas conversion, polymer and plastics production, fine and specialty chemicals, and pharmaceuticals synthesis applications. hte Aktiengesellschaft also sells custom-built hardware and software parallel testing systems and licenses internally developed methods and materials. hte was founded in 1996 by, and is backed by, such investors as 3i Group and BASF.

Hydromer Inc., a bio-polymer research and development company, engages in the research, development, manufacture, licensing, and sale of hydrophilic polymer-based products and services to the medical device, pharmaceutical, animal health, biotechnology, industrial plastics, and cosmetic/personal care markets in the United States and internationally. Hydromer, Inc. owns patents for Hydromer coatings, which are used in materials, such as polyurethane, polyvinyl chloride, and silicone elastomers; ceramics; and metals. Hydromer, Inc. also has patents for permanent anti-fog materials, hydrophilic polyurethane foams, hydrophilic polyurethane blends, hydrophilic polyvinylbutyral alloys, various biocompatible hydrogels, and an anti-bacterial medical material. Hydromer, Inc. OEM medical device portfolio comprises bipolar coagulation probes; placement catheters, biliary stents; jejunal and enteral feeding accessories; guidewires; biofeedback devices for fecal and urinary incontinence; and other endoscopic accessories. In addition, Hydromer, Inc. sells anti-fog/condensation control, an optical coating that prevents the accumulation of vision-obscuring condensation under high humidity conditions for manufacturers of greenhouse panels, refrigerator freezer doors, industrial and medical safety and swim goggles, aircraft windows, automotive headlight assemblies, and gauge and meter manufacturers.

ICON plc, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries primarily in the United States, Ireland, and rest of Europe. ICON plc specializes in strategic development, management, and analysis of programs that support clinical development from compound selection to Phase I to IV clinical studies. The company's clinical research services include investigator recruitment, study monitoring and data collection, case report form preparation, patient safety monitoring, clinical data management, interactive voice response, electronic patient reported outcomes, medical reporting, patient registries, outcomes research, and health economics. ICON plc clinical research services also comprise strategic analysis and data operation, clinical pharmacology, bioanalysis, immunoassay development, pharmacokinetic and pharmacodynamic analysis, study protocol preparation, regulatory consulting, product development planning, strategic consulting, medical imaging, contract staffing, and electronic endpoint adjudication. In addition, ICON plc provides various laboratory services, including sample analysis, safety testing, microbiology, custom flow cytometry, electronic transmission of test results, and biomarker development. ICON plc was founded in 1990 and is headquartered in Dublin, Ireland.

Iconoculture gives clients' better insight into consumers. The research company compiles consumer information -- including patterns and trends on Gen-Xers, Baby Boomers, and various multicultural markets -- and combines it with expert analysis to deliver targeted insights to marketers. IconoIQ is its online, searchable hub for consumer data, market research, and emerging cultural trends covering the US and about 17 international countries across the Americas, Asia, Australia, and Europe. Market research topics include arts and entertainment, health and beauty, sports and fitness, technology, and travel and leisure. Iconoculture, Inc. was founded in 1992 by Mary Meehan and Vickie Abrahamson.

Idaho National Laboratory (INL, formerly Idaho National Engineering and Environmental Laboratory) performs applied engineering research in such areas as nuclear technology, national security, and energy. The laboratory campus, which consists of nearly 570,000 acres, also serves as an environmental research park. Established in 1949, INL is funded by the US Department of Energy and operated by the Battelle Energy Alliance, a partnership of Battelle Memorial Institute, BWX Technologies, Washington Group International, MIT, and the not-for-profit Electric Power Research Institute. The Department of Energy combined the laboratory with the Idaho-based nuclear facilities of Argonne National Laboratory in 2005.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.